1) norfluoxetine
去甲氟西汀
1.
Method:Fluoxetine,norfluoxetine,and clomipramine(internal standard)were extracted into the mixture of n -hexane and acetonitrile(98∶2),and then separated on Eclipse XDB-C 8 column with a mobile phase consisting of 0 05 mol·L -1 phosphate buffer,acetonitrile,and methanol(55∶40∶5),the flow rate was 1 2 mL·min -1 .
目的 :建立一种快速测定人血浆中氟西汀及其代谢产物去甲氟西汀的反相高效液相色谱法。
2.
Background Fluoxetine is metabolized mainly through N-demethylation in the liver and its metabolite norfluoxetine also has pharmacological activity.
背景: 氟西汀主要经过肝脏代谢,其N-去甲基代谢产物去甲氟西汀也具有药理学活性。
3.
Objective:We determined the in vitro effects of three antidepressants,fluoxetine,norfluoxetine and extracts of Saint John\'s Wort,on cyclosporine A(CsA) metabolism via recombinant human CYP3A4,for clinician\'s rational choice of antidepressants in transplantation patients using immunodepressants.
目的:体外考察抗抑郁药氟西汀、去甲氟西汀和圣约翰草提取物对免疫抑制剂环孢素在细胞色素P450酶介导的代谢的影响,为临床器官移植术后合理选择抗抑郁药提供参考。
2) fluoxetine
氟西汀
1.
The cost-effectiveness analysis of depression treatment with fluoxetine,clomipramine and venlafaxine;
氟西汀、氯丙咪嗪、文拉法新治疗抑郁症的成本-效果分析
2.
Enantiomeric Separation of Derivatized Fluoxetine on Chiralcel OD Column;
氟西汀衍生物对映体在纤维素手性固定相上的拆分
3.
Chiral Resolution of Fluoxetine and Cetirizine by Dynamically Dual-coating Capillary Electrochromatography;
氟西汀和西替利嗪对映体的双动态吸附毛细管电色谱手性分离
3) fluxetine
氟西汀
1.
Both accept basic therapy,the acupuncture group is added with acupuncture of strengthening brain and regulating mind,the other with fluxetine;for successive 4 weeks make scores to HRMD mete table,nerve function lack degree and daily life Barthel index.
两组患者均接受基础治疗,针刺组加用健脑调神针法,西药组加用氟西汀,连续4周,进行治疗前后HRMD量表、神经功能缺损程度和日常生活能力Barthel指数评分。
2.
A comparative clinical study for venlafaxine versus fluxetine in the treatment of depression;
方法:将102例抑郁症患者随机分为试验组和对照组各51例,试验组用文拉法辛,起始剂量50mg·d~(-1),7～10d加至75～200mg·d~(-1);对照组用氟西汀,起始剂量为20mg·d~(-1),7～10d内加至40mg·d~(-1),两组疗程均为6周。
4) Fluoxetine hydrochloride
氟西汀
1.
Observation on Effect of Fluoxetine Hydrochloride and Amitriptyline on Treatment of Irritable Bowel Syndrome.;
氟西汀和阿米替林治疗肠易激综合征的疗效观察
2.
Methods 62 patients with persistent somatoform pain disorder were treated with fluoxetine hydrochloride 20mg/d for 6 weeks.
目的探讨氟西汀治疗持续性躯体形式疼痛障碍的疗效及安全性。
3.
Objective:To explore the curative effect of fluoxetine hydrochloride combined with hormone on woman with menopause depresssion.
目的:探讨维尼安联合氟西汀治疗更年期抑郁症的临床疗效,寻求合理有效的治疗方案。
5) Flouxetine
氟西汀
1.
Objective:To compare the efficacy and adverse effects between citalopram and flouxetine in the treatment of dysthymia.
目的:探讨西酞普兰与氟西汀治疗恶劣心境的疗效和安全性。
2.
Mirtazapine vs Flouxetine in treating Parkinson s disease With depressive and anxiety;
目的:比较米氮平与氟西汀治疗帕金森氏病伴发抑郁焦虑的疗效及不良反应。
6) Prozac
氟西汀
1.
The Curative Effect of Prozac on Patients With Depression Caused by Acute Cerebrovascular Disease;
氟西汀治疗急性脑血管病抑郁症的体会
2.
Methods 100 cases of patients with gerontic melancholia were divided into two groups so as to observe the effects and the side-effects of Prozac and amitriptyline working on those patients.
方法将100例老年抑郁症患者随机分成两组,观察氟西汀与阿米替林的疗效及副反应。
3.
All the patients were treated with Lotensin in 10 weeks; meanwhile patients of group 3 also received Prozac (antidepressant).
方法 :77例原发性高血压患者被分成 3组 ,第 1组与第 2组为具有抑郁心态的高血压患者 ,第 3组为无抑郁的高血压对照组 ,3组均用洛丁新降压治疗 10周 ,第 1组同时加用抗抑郁药物氟西汀 (prozac)。
补充资料：氟伐他汀甲酯
分子式：C25H28FNO4
分子量：暂无
CAS号：93957-53-0
性质：该品为浅黄色结晶性粉末。
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：93957-53-0
性质：该品为浅黄色结晶性粉末。
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条